BioCryst Pharmaceuticals

Patent cliffs & loss of exclusivity

A biotechnology company known for developing small-molecule pharmaceuticals for infectious diseases, inflammatory diseases and cancer. It was founded in 1986 and has headquarters in Durham, North Carolina.

Company

AngelList URLhttps://angel.co/biocryst-pharmaceuticals
CAGE Code4GBX7
Legal NameBioCryst Pharmaceuticals, Inc.
Company Operating StatusActive
Contact Page URLhttps://www.biocryst.com/company/contact/
Crunchbase URLhttps://www.crunchbase.com/organization/biocryst-pharmaceuticals
Fax Number833.633.2279
Full Address4505 Emperor Blvd., Suite 200 Durham, NC 27703

7 upcoming patent cliffs

DrugIngredientTypeCliff
  1. RAPIVABPERAMIVIRSmall mol.May 2027
  2. ORLADEYOBEROTRALSTAT DIHYDROCHLORIDESmall mol.May 2040
  3. ORLADEYOBEROTRALSTAT DIHYDROCHLORIDESmall mol.May 2040
  4. ORLADEYOBEROTRALSTAT DIHYDROCHLORIDESmall mol.May 2040
  5. ORLADEYOBEROTRALSTAT DIHYDROCHLORIDESmall mol.May 2040
  6. ORLADEYOBEROTRALSTAT DIHYDROCHLORIDESmall mol.May 2040
  7. ORLADEYOBEROTRALSTAT DIHYDROCHLORIDESmall mol.May 2040

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

BioCryst Pharmaceuticals — patent cliffs & loss of exclusivity | CliffBio